Fig. 8: Hemocompatibility and biocompatibility of anticoagulant supercapacitors in vivo.
From: An anticoagulant supercapacitor for implantable applications
a Schematic diagram of implantation, b digital photograph of the 1st day, 15th day, 90th day after implantation, and the dissection on 90th day after implantation, c anticoagulant performance, d blood routine (WBC white blood cell count, NEUT neutrophils, LYM lymphocytes, RBC red blood cell count, HGB hemoglobin concentration, and PLT platelet count), e H&E and toluidine blue staining at the implant regions on the blank control and implanted tissues, and f statistical analysis of mast cells of the blank control and implanted tissues. The cartoon mouse is by Figdraw (www.figdraw.com) (a). The similar results are repeated in three independent experiments (b, e). Data were presented as mean ± SD (n = 3 independent samples) (c, d, f). Statistical analysis by one-way ANOVA with Turkey’s multiple comparisons test (*p < 0.05 and **p < 0.01) (f).
